|
Título:
|
Voriconazole as a first-line treatment against potentially pathogenic Acanthamoeba strains from Peru
|
|
Autores:
|
Cabello-Vílchez, A.M. ;
Martín-Navarro, C.M. ;
López-Arencibia, A. ;
Reyes-Batlle, M. ;
Sifaoui, I. ;
Valladares, B. ;
Piñero, J.E. ;
Lorenzo-Morales, J.
|
|
Tipo de documento:
|
texto impreso
|
|
Editorial:
|
Springer Verlag, 2020-06-10T18:12:13Z
|
|
Nota general:
|
info:eu-repo/semantics/restrictedAccess
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
|
|
Idiomas:
|
Inglés
|
|
Palabras clave:
|
Editados por otras instituciones
,
Artículos
,
Artículos en revistas indizadas
|
|
Resumen:
|
Pathogenic strains of Acanthamoeba genus are the causative agents of fatal granulomatous amoebic encephalitis and a serious sight-threatening infection of the eye known as Acanthamoeba keratitis. In a previous study, Acanthamoeba strains were isolated from nasal swabs collected from healthy individuals in Peru. In the present study, the pathogenic potential of the isolated strains was established based on temperature and osmotolerance assays as well as the secretion rate of extracellular proteases. Based on these experiments, four strains that showed the highest pathogenic potential were selected for sensitivity assays against two molecules (voriconazole and chlorhexidine) which are currently used for the treatment of Acanthamoeba infections. After performing sensitivity and activity assays, it was found that both drugs were active against the tested strains. However, voriconazole showed higher activity against the studied strains compared to chlorhexidine. Therefore, voriconazole should be established as a first-line treatment against Acanthamoeba infections at least in the studied region of Peru. © 2013 Springer-Verlag Berlin Heidelberg.
|
|
En línea:
|
http://doi.org/10.1007/s00436-013-3705-8
|
